Yuvimont LC 5mg/10mg Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, indicated for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms like sneezing, nasal congestion, itching, and rhinorrhea. Montelukast, a leukotriene receptor antagonist, blocks cysteinyl leukotriene receptors, preventing bronchoconstriction, inflammation, and mucus production associated with allergic responses. The synergistic action of these agents provides comprehensive relief from both nasal and systemic allergic manifestations. Yuvimont LC is typically prescribed for adults and children above 15 years, with dosage and duration tailored to the severity of symptoms and clinical response. It is well tolerated, though mild side effects such as headache, fatigue, dry mouth, or gastrointestinal discomfort may occur. Caution is advised in patients with hepatic impairment or a history of neuropsychiatric events. This combination therapy is not recommended during pregnancy unless clearly necessary. Patients should avoid alcohol and consult healthcare providers regarding potential drug interactions. Yuvimont LC offers an effective therapeutic option for improving quality of life in patients suffering from allergic disorders by targeting multiple inflammatory pathways.